EHWM
CVS icon

Eads & Heald Wealth Management’s CVS Health CVS Stock Holding History

Eads & Heald Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$780K Hold
10,863
– – 0.39% 91
2025
Q4 		$862K Sell
10,863
-407
-4% -$32.1K 0.42% 90
2025
Q3 		$850K Sell
11,270
-390
-3% -$26.7K 0.41% 91
2025
Q2 		$804K Buy
11,660
+548
+5% +$35.9K 0.4% 97
2025
Q1 		$753K Sell
11,112
-139
-1% -$8.32K 0.38% 99
2024
Q4 		$505K Sell
11,251
-3,383
-23% -$190K 0.25% 112
2024
Q3 		$920K Sell
14,634
-1,033
-7% -$60.3K 0.44% 90
2024
Q2 		$925K Sell
15,667
-3,399
-18% -$213K 0.45% 87
2024
Q1 		$1.52M Sell
19,066
-1,655
-8% -$126K 0.71% 66
2023
Q4 		$1.64M Sell
20,721
-1,664
-7% -$118K 0.79% 61
2023
Q3 		$1.56M Sell
22,385
-1,449
-6% -$103K 0.82% 56
2023
Q2 		$1.65M Sell
23,834
-1,481
-6% -$105K 0.81% 58
2023
Q1 		$1.88M Buy
25,315
+1,100
+5% +$92.2K 0.93% 47
2022
Q4 		$2.26M Buy
24,215
+1,059
+5% +$102K 1.15% 34
2022
Q3 		$2.21M Buy
23,156
+262
+1% +$25.9K 1.25% 24
2022
Q2 		$2.12M Sell
22,894
-233
-1% -$22.7K 1.14% 32
2022
Q1 		$2.34M Sell
23,127
-2,085
-8% -$219K 1.08% 37
2021
Q4 		$2.6M Sell
25,212
-1,010
-4% -$93.3K 1.13% 30
2021
Q3 		$2.23M Buy
26,222
+1,432
+6% +$120K 1.07% 37
2021
Q2 		$2.07M Sell
24,790
-620
-2% -$50.8K 1.01% 42
2021
Q1 		$1.91M Buy
25,410
+19
+0.1% +$1.38K 0.98% 46
2020
Q4 		$1.73M Buy
25,391
+731
+3% +$47.5K 0.93% 51
2020
Q3 		$1.44M Buy
24,660
+7,385
+43% +$460K 0.86% 56
2020
Q2 		$1.12M Buy
17,275
+733
+4% +$46.2K 0.68% 69
2020
Q1 		$981K Buy
16,542
+88
+0.5% +$5.88K 0.69% 68
2019
Q4 		$1.22M Buy
16,454
+2,023
+14% +$142K 0.65% 73
2019
Q3 		$910K Buy
14,431
+6,421
+80% +$380K 0.51% 83
2019
Q2 		$436K Sell
8,010
-1,581
-16% -$85.1K 0.25% 109
2019
Q1 		$517K Buy
9,591
+420
+5% +$25.9K 0.3% 105
2018
Q4 		$601K Buy
9,171
+65
+0.7% +$4.85K 0.4% 95
2018
Q3 		$717K Sell
9,106
-40
-0.4% -$2.86K 0.41% 94
2018
Q2 		$589K Buy
9,146
+250
+3% +$16.5K 0.36% 99
2018
Q1 		$553K Sell
8,896
-6,928
-44% -$497K 0.35% 100
2017
Q4 		$1.15M Sell
15,824
-884
-5% -$64.3K 0.68% 74
2017
Q3 		$1.36M Buy
16,708
+30
+0.2% +$2.37K 0.84% 56
2017
Q2 		$1.34M Sell
16,678
-388
-2% -$30.6K 0.86% 55
2017
Q1 		$1.34M Buy
17,066
+2,864
+20% +$229K 0.86% 61
2016
Q4 		$1.12M Sell
14,202
-221
-2% -$17.9K 0.76% 67
2016
Q3 		$1.28M Sell
14,423
-40
-0.3% -$3.78K 0.88% 55
2016
Q2 		$1.39M Sell
14,463
-130
-0.9% -$13K 0.95% 51
2016
Q1 		$1.51M Sell
14,593
-343
-2% -$33.4K 1.05% 42
2015
Q4 		$1.46M Sell
14,936
-90
-0.6% -$8.81K 1.01% 41
2015
Q3 		$1.45M Sell
15,026
-527
-3% -$55.4K 1.03% 38
2015
Q2 		$1.63M Sell
15,553
-270
-2% -$27.6K 1.07% 38
2015
Q1 		$1.63M Sell
15,823
-1,728
-10% -$175K 1.05% 39
2014
Q4 		$1.69M Buy
17,551
+558
+3% +$49.2K 1.07% 41
2014
Q3 		$1.35M Sell
16,993
-194
-1% -$15.3K 0.91% 52
2014
Q2 		$1.29M Sell
17,187
-675
-4% -$51K 0.86% 57
2014
Q1 		$1.34M Sell
17,862
-1,800
-9% -$127K 0.88% 57
2013
Q4 		$1.41M Sell
19,662
-880
-4% -$56.5K 0.93% 55
2013
Q3 		$1.17M Sell
20,542
-305
-1% -$18.2K 0.83% 60
2013
Q2 		$1.19M Buy
+20,847
New +$1.21M 0.84% 59

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Eads & Heald Wealth Management's CVS Position: Q1 2026 in Review

Eads & Heald Wealth Management held its CVS Health (CVS) position steady in Q1 2026 at 10,863 shares worth $780K. The position accounts for 0.39% of the portfolio, ranked #91.

Eads & Heald Wealth Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.6M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Eads & Heald Wealth Management held 10,863 shares of CVS Health worth $780K as of Q1 2026.
  • Eads & Heald Wealth Management left its CVS Health share count unchanged in Q1 2026.
  • CVS Health made up 0.39% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #91 holding.
  • Eads & Heald Wealth Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Eads & Heald Wealth Management's CVS Health position peaked at $2.6M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.